Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression

• Status: Completed
• Trial end date: 2020-05-31
• Target enrollment: 0
• Participant gender: All

Summary

Brief Summary: Purpose of this study is to evaluate efficacy of hydroxychloroquine (HCQ) in reducing progression of Corona Virus Disease 2019 (COVID - 19) and achieving viral clearance.

Condition or disease :I COVID-19 ntervention/treatment :Drug: Hydroxychloroquine Sulfate Phase: Phase III

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: UNICEF
• Collaborators: Pak Emirates Military Hospital Rawalpindi; Pak Emirates Military Hospital Rawalpindi, Pakistan

Criteria

Inclusion Criteria:

• Mild Corona virus disease (COVID-19)

• PCR confirmed infection

• Hospital admitted patients

Exclusion Criteria:

• Moderate, severe and critical COVID-19

• day 0 CRP greater than 6mg/dl, ALC < 1000 or evidence of infiltrates on X-ray chest

• comorbidity with life expectancy less than 6 months

• Contraindications to HCQ therapy